Osteoporosis and bone health in patients with lung disease.
Osteoporosis is a common systemic disease whose presentation crosses many specialties in medicine. Low bone mass, (osteopenia) and osteoporosis increases a patient's risk of suffering from a fracture, and fragility fractures are known to have a significant effect on morbidity and mortality, with up to a 1-year 20% mortality risk. Early detection of osteoporosis is essential to reduce a patient's risk of fracture. Several diseases are associated with an increased risk of osteoporosis because of the medications used to treat these diseases, including but not limited to the prescribing of glucocorticoids. It is important to recognize which patients warrant therapy for bone health and to implement medical management as appropriate.
Bolster
Marcy B
MB
Medical University of South Carolina, Charleston, SC 29425, USA. bolsterm@musc.edu
D019091:Critical Pathways; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D008171:Lung Diseases / Q000150:complications* / Q000188:drug therapy*; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology*
D005938:Glucocorticoids